ESR1 and breast carcinoma: Furthermore, the molecular docking study revealed that 47 and 49 showed strong bond-free energy (−8.8 kcal/mol and -8.7 kcal/mol, respectively) to estrogen receptor-α (ERα), therefore they inhibited ERα in breast cancer cells [98].